Having demonstrated that IGFBP‐4 exerts antifibrotic effects in vitro and ex vivo, we tested its ability to ameliorate fibrosis in vivo in a murine bleomycin‐induced pulmonary fibrosis model. Here, IGFBP4 is linked to pulmonary fibrosis.